Muneer A Satter

CIK 1315797 · See Remarks · last filed 2026-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$36.92M
Companies
6
Total Filings
66
Lifetime Open-Market Net
$89.31M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ANNX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O SATTER INVESTMENT MANAGEMENT, LLC
676 NORTH MICHIGAN AVENUE, SUITE 4000
CHICAGO, IL 60611
Related Filers
PDS Biotechnology Corp — 3 joint filings, latest 2019-02-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANNX Director 10,342,134 $3.44 $35.63M $43.81M 13 2026-06-15
Rein Therapeutics, Inc. (ALRN) Delisted See Remarks 830,472 $2.11 $1.75M $14.47M 3 2021-01-08
Whitehawk Therapeutics, Inc. (ARPO) Delisted Director 374,789 $33.00 $12.37M $8.10M 11 2019-06-19
AKBA Director 3,037,042 $0.42 $1.29M $20.68M 17 2018-06-15
Eledon Pharmaceuticals, Inc. (TKAI) Delisted 10%+ Owner 196,854 — — $2.25M 1 2014-09-24
HeartWare International, Inc. (HTWR) Delisted 10%+ Owner 1,085,718 — — $88 1 2009-08-14

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
ANNX See footnote 10,342,134 100.0% 2026-05-29
Total 10,342,134
ALRN Muneer A. Satter Revocable Trust and various other trusts and entities
See Footnote
830,472 100.0% 2021-01-08
Total 830,472
ARPO See footnote 374,789 100.0% 2019-01-10
Total 374,789
AKBA See Footnotes 3,037,042 100.0% 2017-07-11
Total 3,037,042
No longer reported
See Footnote 2,002,560 — last 2015-04-22
TKAI See footnote. 196,854 100.0% 2014-09-24
Total 196,854
HTWR By Muneer A. Satter Revocable Trust 714,286 65.8% 2009-08-14
By Satter Children's Trust 285,715 26.3% 2009-08-14
By Satter Family Trust 57,143 5.3% 2009-08-14
By Kristen Hayler Hertel Revocable Trust 8,572 0.8% 2009-08-14
By Rabi H. Satter Insurance Trust 4,286 0.4% 2009-08-14
By Gordon and Barbara Anne Hertel Insurance Trust 4,286 0.4% 2009-08-14
By Anne-Carole Witort Insurance Trust 4,286 0.4% 2009-08-14
By Rose Shereen Fuqua Insurance Trust 4,286 0.4% 2009-08-14
By Abdus Satter Insurance Trust 2,858 0.3% 2009-08-14
Total 1,085,718

Recent Filings · Page 2 of 7

66 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2022-06-13 ANNX Grant (A) — $0 EDGAR
2021-06-04 ANNX Grant (A) — $0 EDGAR
2021-01-08 Rein Therapeutics, Inc. (ALRN) Delisted Buy (P) +9,000,000 $9.90M EDGAR
2020-07-28 ANNX Mixed +1,954,978 $3.40M EDGAR
2020-06-09 Rein Therapeutics, Inc. (ALRN) Delisted Buy (P) +3,700,000 $4.07M EDGAR
2019-06-19 Whitehawk Therapeutics, Inc. (ARPO) Delisted Grant (A) — $0 EDGAR
2019-01-10 Whitehawk Therapeutics, Inc. (ARPO) Delisted Buy (P) +63,818 $150.3K EDGAR
2019-01-07 Whitehawk Therapeutics, Inc. (ARPO) Delisted Buy (P) +60,000 $127.5K EDGAR
2019-01-02 Whitehawk Therapeutics, Inc. (ARPO) Delisted Buy (P) +60,000 $108.1K EDGAR
2018-12-27 Whitehawk Therapeutics, Inc. (ARPO) Delisted Buy (P) +60,000 $104.1K EDGAR
Showing 11–20 of 66
Page 2 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).